IO Biotech Inc
NASDAQ:IOBT

Watchlist Manager
IO Biotech Inc Logo
IO Biotech Inc
NASDAQ:IOBT
Watchlist
Price: 0.6645 USD 6.83% Market Closed
Market Cap: 47.8m USD

Operating Margin
IO Biotech Inc

0%
Current
0%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-92.1m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

IO Biotech Inc
Glance View

Market Cap
46.3m USD
Industry
Biotechnology

IO Biotech, Inc. is a clinical stage biotechnology company. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The firm develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The firm is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.

IOBT Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-92.1m
/
Revenue
0
What is the Operating Margin of IO Biotech Inc?

Based on IO Biotech Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top